Related Experiment Video
Updated: Jul 16, 2025
06:34
Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
Published on: November 29, 2024
285
Gout therapeutics and drug delivery
Xiuju Peng1, Xiaotong Li1, Bing Xie1
1Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing 2111198, PR China.
Summary
Gout, a growing inflammatory arthritis, requires advanced drug delivery systems (DDS) to overcome limitations of current treatments. This review explores DDS innovations for better gout management and therapy.
Area of Science:
- Rheumatology
- Nanotechnology
- Pharmaceutical Sciences
Background:
- Gout is a prevalent inflammatory arthritis linked to elevated uric acid levels, with increasing incidence due to lifestyle and medication factors.
- Current pharmacological treatments for gout face challenges including poor chemical stability and limited targeting, leading to suboptimal efficacy and safety.
- The growing global health burden of gout necessitates novel therapeutic strategies beyond conventional drug administration.
Purpose of the Study:
- To review the pathological features and therapeutic targets of gout.
- To examine existing and emerging pharmacological treatments for gout.
- To comprehensively summarize the development of advanced drug delivery systems (DDS) for enhanced gout management.
Main Methods:
- Literature review of gout pathology, therapeutic targets, and clinical drugs.
- Analysis of current research on drug delivery systems for gout therapy.
- Categorization of DDS based on carrier types: lipid, polymeric, and inorganic.
Main Results:
- Traditional gout medications exhibit pharmaceutical shortcomings impacting treatment outcomes.
- Advanced DDS utilizing various carriers show promise in overcoming the limitations of conventional gout drugs.
- Recent research highlights the potential of lipid, polymeric, and inorganic DDS for improved gout management.
Conclusions:
- Drug delivery systems offer a promising avenue to enhance the efficacy and safety of gout treatment.
- Further development and application of tailored DDS are crucial for effective gout therapy.
- Innovations in DDS are essential to address the increasing global burden of gout.
Related Concept Videos
01:22Drug Delivery: Miscellaneous Routes
377
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
377
01:16Drug Delivery: Overview
321
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
321
01:26Targets for Drug Action: Overview
6.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.4K
01:27Peripheral Artery Disease III: Interprofessional Care
11
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11
01:21Drug Distribution: Tissue Binding
2.7K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.7K
01:24Principles of Drug Action
6.1K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.1K